PMID- 33924998 OWN - NLM STAT- MEDLINE DCOM- 20210922 LR - 20210922 IS - 2218-273X (Electronic) IS - 2218-273X (Linking) VI - 11 IP - 5 DP - 2021 Apr 28 TI - Rapamycin Improves Spatial Learning Deficits, Vulnerability to Alcohol Addiction and Altered Expression of the GluN2B Subunit of the NMDA Receptor in Adult Rats Exposed to Ethanol during the Neonatal Period. LID - 10.3390/biom11050650 [doi] LID - 650 AB - Ethanol exposure during pregnancy alters the mammalian target of rapamycin (mTOR) signaling pathway in the fetal brain. Hence, in adult rats exposed to ethanol during the neonatal period, we investigated the influence of rapamycin, an mTOR Complex 1 (mTORC1) inhibitor, on deficits in spatial memory and reversal learning in the Barnes maze task, as well as the ethanol-induced rewarding effects (1.0 or 1.5 g/kg) using the conditioning place preference (CPP) paradigm. Rapamycin (3 and 10 mg/kg) was given before intragastric ethanol (5 g/kg/day) administration at postnatal day (PND)4-9 (an equivalent to the third trimester of human pregnancy). Spatial memory/reversal learning and rewarding ethanol effect were evaluated in adult (PND60-70) rats. Additionally, the impact of rapamycin pre-treatment on the expression of the GluN2B subunit of NMDA receptor in the brain was assessed in adult rats. Our results show that neonatal ethanol exposure induced deficits in spatial memory and reversal learning in adulthood, but the reversal learning outcome may have been due to spatial learning impairments rather than cognitive flexibility impairments. Furthermore, in adulthood the ethanol treated rats were also more sensitive to the rewarding effect of ethanol than the control group. Rapamycin prevented the neonatal effect of ethanol and normalized the GluN2B down-regulation in the hippocampus and the prefrontal cortex, as well as normalized this subunit's up-regulation in the striatum of adult rats. Our results suggest that rapamycin and related drugs may hold promise as a preventive therapy for fetal alcohol spectrum disorders. FAU - Lopatynska-Mazurek, Malgorzata AU - Lopatynska-Mazurek M AUID- ORCID: 0000-0001-5266-1968 AD - Department of Pharmacology and Pharmacodynamics, Medical University, Chodzki 4A, 20-093 Lublin, Poland. FAU - Antolak, Anna AU - Antolak A AUID- ORCID: 0000-0002-8008-8684 AD - Department of Analytical Chemistry and Biochemistry, Faculty of Materials Sciences and Ceramics, AGH University of Science and Technology, Mickiewicza 30 Ave., 30-059 Krakow, Poland. FAU - Grochecki, Pawel AU - Grochecki P AD - Department of Pharmacology and Pharmacodynamics, Medical University, Chodzki 4A, 20-093 Lublin, Poland. FAU - Gibula-Tarlowska, Ewa AU - Gibula-Tarlowska E AUID- ORCID: 0000-0001-7791-0633 AD - Department of Pharmacology and Pharmacodynamics, Medical University, Chodzki 4A, 20-093 Lublin, Poland. FAU - Bodzon-Kulakowska, Anna AU - Bodzon-Kulakowska A AUID- ORCID: 0000-0002-0158-8059 AD - Department of Analytical Chemistry and Biochemistry, Faculty of Materials Sciences and Ceramics, AGH University of Science and Technology, Mickiewicza 30 Ave., 30-059 Krakow, Poland. FAU - Listos, Joanna AU - Listos J AD - Department of Pharmacology and Pharmacodynamics, Medical University, Chodzki 4A, 20-093 Lublin, Poland. FAU - Kedzierska, Ewa AU - Kedzierska E AD - Department of Pharmacology and Pharmacodynamics, Medical University, Chodzki 4A, 20-093 Lublin, Poland. FAU - Suder, Piotr AU - Suder P AUID- ORCID: 0000-0003-4511-1241 AD - Department of Analytical Chemistry and Biochemistry, Faculty of Materials Sciences and Ceramics, AGH University of Science and Technology, Mickiewicza 30 Ave., 30-059 Krakow, Poland. FAU - Silberring, Jerzy AU - Silberring J AD - Department of Analytical Chemistry and Biochemistry, Faculty of Materials Sciences and Ceramics, AGH University of Science and Technology, Mickiewicza 30 Ave., 30-059 Krakow, Poland. FAU - Kotlinska, Jolanta H AU - Kotlinska JH AUID- ORCID: 0000-0002-4178-1515 AD - Department of Pharmacology and Pharmacodynamics, Medical University, Chodzki 4A, 20-093 Lublin, Poland. LA - eng GR - DS 22/2020/Medical University of Lublin/ PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20210428 PL - Switzerland TA - Biomolecules JT - Biomolecules JID - 101596414 RN - 0 (NR2B NMDA receptor) RN - 0 (Receptors, N-Methyl-D-Aspartate) RN - 3K9958V90M (Ethanol) RN - W36ZG6FT64 (Sirolimus) SB - IM MH - Alcoholism/metabolism MH - Animals MH - Animals, Newborn/metabolism MH - Brain/drug effects MH - Ethanol/*toxicity MH - Female MH - Fetal Alcohol Spectrum Disorders/drug therapy MH - Hippocampus/drug effects MH - Male MH - Prefrontal Cortex/drug effects MH - Rats MH - Rats, Wistar MH - Receptors, N-Methyl-D-Aspartate/genetics/metabolism MH - Signal Transduction/drug effects MH - Sirolimus/metabolism/*pharmacology MH - Spatial Learning/*drug effects/physiology PMC - PMC8147055 OTO - NOTNLM OT - adult rats 5 OT - neonatal ethanol exposure 4 OT - rapamycin 1 OT - reward 3 OT - spatial learning 2 COIS- The authors declare no conflict of interest. EDAT- 2021/05/01 06:00 MHDA- 2021/09/23 06:00 PMCR- 2021/04/28 CRDT- 2021/04/30 01:30 PHST- 2021/03/19 00:00 [received] PHST- 2021/04/23 00:00 [revised] PHST- 2021/04/24 00:00 [accepted] PHST- 2021/04/30 01:30 [entrez] PHST- 2021/05/01 06:00 [pubmed] PHST- 2021/09/23 06:00 [medline] PHST- 2021/04/28 00:00 [pmc-release] AID - biom11050650 [pii] AID - biomolecules-11-00650 [pii] AID - 10.3390/biom11050650 [doi] PST - epublish SO - Biomolecules. 2021 Apr 28;11(5):650. doi: 10.3390/biom11050650.